Beacon Pointe Advisors’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
13,199
-3,474
-21% -$327K 0.01% 950
2026
Q1
$1.48M Sell
16,673
-44,022
-73% -$4.52M 0.01% 844
2025
Q4
$5.78M Sell
60,695
-30,685
-34% -$3.09M 0.04% 355
2025
Q3
$9.01M Buy
91,380
+3,339
+4% +$357K 0.08% 244
2025
Q2
$9.37M Sell
88,041
-1,475
-2% -$149K 0.1% 191
2025
Q1
$8.15M Sell
89,516
-505
-0.6% -$56.5K 0.09% 204
2024
Q4
$10.3M Buy
90,021
+1,659
+2% +$189K 0.11% 168
2024
Q3
$10.5M Buy
88,362
+3,335
+4% +$307K 0.12% 159
2024
Q2
$6.83M Sell
85,027
-10,795
-11% -$987K 0.08% 218
2024
Q1
$8.84M Buy
95,822
+43,116
+82% +$4.13M 0.1% 187
2023
Q4
$5.56M Buy
+52,706
New +$5.31M 0.07% 254
2022
Q3
Sell
-1,569
Closed -$234K 1012
2022
Q2
$234K Buy
+1,569
New +$240K ﹤0.01% 919
2021
Q4
Sell
-959
Closed -$262K 936
2021
Q3
$262K Hold
959
0.01% 756
2021
Q2
$215K Buy
+959
New +$181K 0.01% 777

Other funds holding BNTX

Beacon Pointe Advisors's BNTX Position: Q2 2026 in Review

Beacon Pointe Advisors reduced its BioNTech (BNTX) stake by 21% in Q2 2026, selling an estimated $327K and leaving 13,199 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #950.

Beacon Pointe Advisors first reported a position in BNTX in Q2 2021 and has held it in 14 quarters since. The position peaked at $10.5M in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Beacon Pointe Advisors held 13,199 shares of BioNTech worth $1.23M as of Q2 2026.
  • Beacon Pointe Advisors sold 3,474 BioNTech shares in Q2 2026, an estimated $327K.
  • BioNTech made up 0.01% of Beacon Pointe Advisors's portfolio in Q2 2026, its #950 holding.
  • Beacon Pointe Advisors first reported a position in BioNTech in Q2 2021 and has held it in 14 quarters since.
  • Beacon Pointe Advisors's BioNTech position peaked at $10.5M in Q3 2024.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.